erythromycin propionate-n-acetylcysteinate has been researched along with brefeldin a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boittin, FX; Dorchies, OM; Patthey-Vuadens, O; Reutenauer-Patte, J; Ruegg, UT | 1 |
1 other study(ies) available for erythromycin propionate-n-acetylcysteinate and brefeldin a
Article | Year |
---|---|
Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways.
Topics: Acetylcysteine; Animals; Brefeldin A; Calcium; Calcium Channels; Cyclic AMP-Dependent Protein Kinases; Erythromycin; Group VI Phospholipases A2; Injections, Intradermal; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle Relaxation; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Animal; Protein Kinase Inhibitors; Protein Synthesis Inhibitors; Receptors, Corticotropin-Releasing Hormone; Stromal Interaction Molecule 1; Urocortins | 2012 |